Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (4867)	7/13/1998 12:51:00 PM
From: JimieA	of 6136

An article in the Boston Globe for the technically challenged readers. AIDS drug quest Simpler regimens coming soon, but they won't work for all Drugs in the pipeline, and others not far behind, introduce the possibility of effective regimens that don't require protease inhibitors, the potent antivirals that made the big difference two years ago in combination with older drugs. If so, protease inhibitors can be held in reserve for those whose virus rebounds after first-line therapy. boston.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next